Scholars@Duke publication: Subcutaneous injection of a cyclic peptide antagonist of vitronectin receptor-type integrins inhibits retinal neovascularization.

Subcutaneous injection of a cyclic peptide antagonist of vitronectin receptor-type integrins inhibits retinal neovascularization.

Publication , Journal Article

Flynn, JT; Cousins, S

Published in: Surv Ophthalmol

1996

Published version (DOI) Link to item

Duke Scholars

Author Scott William Cousins Ophthalmology, Vitreoretinal Diseases & Surgery

Published In

Surv Ophthalmol

DOI

10.1016/s0039-6257(96)80032-4

ISSN

0039-6257

Publication Date

1996

Volume

Issue

Start / End Page

271 / 272

Location

United States

Related Subject Headings

Retinal Neovascularization
Receptors, Vitronectin
Peptides, Cyclic
Ophthalmology & Optometry
Mice
Integrins
Injections, Subcutaneous
Hypoxia
Dose-Response Relationship, Drug
Animals

Citation

APA

Chicago

ICMJE

MLA

NLM

Flynn, J. T., & Cousins, S. (1996). Subcutaneous injection of a cyclic peptide antagonist of vitronectin receptor-type integrins inhibits retinal neovascularization. Surv Ophthalmol, 41(3), 271–272. https://doi.org/10.1016/s0039-6257(96)80032-4

Flynn, J. T., and S. Cousins. “Subcutaneous injection of a cyclic peptide antagonist of vitronectin receptor-type integrins inhibits retinal neovascularization.” Surv Ophthalmol 41, no. 3 (1996): 271–72. https://doi.org/10.1016/s0039-6257(96)80032-4.

Flynn JT, Cousins S. Subcutaneous injection of a cyclic peptide antagonist of vitronectin receptor-type integrins inhibits retinal neovascularization. Surv Ophthalmol. 1996;41(3):271–2.

Flynn, J. T., and S. Cousins. “Subcutaneous injection of a cyclic peptide antagonist of vitronectin receptor-type integrins inhibits retinal neovascularization.” Surv Ophthalmol, vol. 41, no. 3, 1996, pp. 271–72. Pubmed, doi:10.1016/s0039-6257(96)80032-4.

Flynn JT, Cousins S. Subcutaneous injection of a cyclic peptide antagonist of vitronectin receptor-type integrins inhibits retinal neovascularization. Surv Ophthalmol. 1996;41(3):271–272.

Published In

Surv Ophthalmol

DOI

10.1016/s0039-6257(96)80032-4

ISSN

0039-6257

Publication Date

1996

Volume

Issue

Start / End Page

271 / 272

Location

United States

Related Subject Headings

Retinal Neovascularization
Receptors, Vitronectin
Peptides, Cyclic
Ophthalmology & Optometry
Mice
Integrins
Injections, Subcutaneous
Hypoxia
Dose-Response Relationship, Drug
Animals